Lantern Pharma Inc. Common Stock
Symbol: LTRN (NASDAQ)
4.42
▲ (1.61%) 0.070
Company Description:
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
Key Stats
- Today's Open: $4.42
- Today's High: $4.42
- Today's Low: $4.42
- Today's Volume: 637
- Yesterday Close: $4.35
- Yesterday High: $4.54
- Yesterday Low: $4.28
- Yesterday Volume: 807.39K
- Last Min Volume: 7
- Last Min High: $4.42
- Last Min Low: $4.42
- Last Min VWAP: $4.42
Company Profile
- Name: Lantern Pharma Inc. Common Stock
- Website: https://www.lanternpharma.com
- Listed Date: 2020-06-11
- Location: DALLAS, TX
- Market Status: Active
- CIK Number: 0001763950
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $49.03M
- Round Lot: 100
- Outstanding Shares: 10.80M
- Asset Type: CS
RECENT FILINGS FOR LTRN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-23 | 8-K | View |
| 2025-09-23 | 4 | View |
| 2025-09-23 | 4 | View |
| 2025-09-23 | 4 | View |
| 2025-09-23 | 4 | View |
| 2025-09-23 | 4 | View |
| 2025-09-23 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-13 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-11 | ARS | View |
| 2025-08-08 | DEF 14A | View |
| 2025-07-30 | 3 | View |
| 2025-07-29 | 8-K | View |
| 2025-07-28 | PRE 14A | View |
| 2025-07-03 | 8-K | View |
| 2025-07-03 | 424B5 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | SCHEDULE 13D/A | View |
Latest News on LTRN